David M. Charytan

机构：NYU Langone Health, Kidney Care UK, New York University · ORCID：0000-0002-7695-3583

发表论文 312 篇 · 总被引 23278 次 · h-index 59

代表论文

• GLP-1 Receptor Agonist Outcomes, Safety, and Body Mass Index Change in a National Cohort of Patients on Dialysis (2025 · Clinical Journal of the American Society of Nephrology · 被引 30)
• SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors (2025 · JAMA Internal Medicine · 被引 25)
• Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis (2025 · Diabetes Care · 被引 17)
• Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, a Multi-Dialysis Center 2 × 2 Factorial Block-Randomized Controlled Trial (2025 · American Journal of Nephrology · 被引 8)
• Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community‐Based Study (2025 · Journal of the American Heart Association · 被引 7)
• Fall Risk in Maintenance Hemodialysis Patients (2025 · Clinical Journal of the American Society of Nephrology · 被引 4)